ATE274354T1 - Impfungsmethode zur effizienten induktion der t- lymphozyten zytotoxischantwort - Google Patents
Impfungsmethode zur effizienten induktion der t- lymphozyten zytotoxischantwortInfo
- Publication number
- ATE274354T1 ATE274354T1 AT00905548T AT00905548T ATE274354T1 AT E274354 T1 ATE274354 T1 AT E274354T1 AT 00905548 T AT00905548 T AT 00905548T AT 00905548 T AT00905548 T AT 00905548T AT E274354 T1 ATE274354 T1 AT E274354T1
- Authority
- AT
- Austria
- Prior art keywords
- epitope
- cytotoxic response
- efficient induction
- vaccination method
- mhc class
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11540599P | 1999-01-08 | 1999-01-08 | |
PCT/US2000/000286 WO2000040261A2 (en) | 1999-01-08 | 2000-01-06 | Vaccination method for efficient induction of cytotoxic t lymphocyte response |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE274354T1 true ATE274354T1 (de) | 2004-09-15 |
Family
ID=22361181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00905548T ATE274354T1 (de) | 1999-01-08 | 2000-01-06 | Impfungsmethode zur effizienten induktion der t- lymphozyten zytotoxischantwort |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1140162B1 (de) |
AT (1) | ATE274354T1 (de) |
AU (1) | AU2720600A (de) |
DE (1) | DE60013242D1 (de) |
WO (1) | WO2000040261A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
DE60238864D1 (de) | 2001-11-07 | 2011-02-17 | Mankind Corp | Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ235315A (en) * | 1989-09-19 | 1991-09-25 | Wellcome Found | Chimaeric hepadnavirus core antigen proteins and their construction |
-
2000
- 2000-01-06 WO PCT/US2000/000286 patent/WO2000040261A2/en not_active Application Discontinuation
- 2000-01-06 DE DE60013242T patent/DE60013242D1/de not_active Expired - Lifetime
- 2000-01-06 AU AU27206/00A patent/AU2720600A/en not_active Abandoned
- 2000-01-06 EP EP00905548A patent/EP1140162B1/de not_active Revoked
- 2000-01-06 AT AT00905548T patent/ATE274354T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2720600A (en) | 2000-07-24 |
WO2000040261A3 (en) | 2000-11-30 |
EP1140162B1 (de) | 2004-08-25 |
WO2000040261A2 (en) | 2000-07-13 |
EP1140162A2 (de) | 2001-10-10 |
DE60013242D1 (de) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69333814D1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
IL181687A0 (en) | A method of inducing a ctl response | |
WO2001091536A3 (en) | Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens | |
DE69532672D1 (de) | Methode zur induktion mit immunantwort mittels expression eines heterologen immunogens in lebenden venezulanischen pferde-encephalitisviren | |
WO2002034205A3 (en) | Using heat shock proteins to increase immune response | |
EP1270016A4 (de) | Aidsvirus-impfstoff unter verwendung eines sendaivirus-vektors | |
ATE300950T1 (de) | Chimäre cdna-klone des virus der infektiösen bursal-krankheit, expressionsprodukte und darauf basierende impfstoffe | |
AP2003002734A0 (en) | Purification of HBV antigens for use in vaccines. | |
AU1013601A (en) | Method of inducing and/or enhancing an immune response to tumor antigens | |
ATE17320T1 (de) | Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben. | |
GB9406492D0 (en) | Malaria peptides | |
ATE274354T1 (de) | Impfungsmethode zur effizienten induktion der t- lymphozyten zytotoxischantwort | |
WO2003103570A3 (en) | TRANSCUTANEOUS IMMUNIZATION AGAINST PAPILLOMAVIRUS WITH A PAPILLOMAVIRUS VIRUS | |
NO940827D0 (no) | Parenteral immunisering mot rotavirus | |
MY141983A (en) | Hepatitis b virus surface antigen as a mucosal immunoenhancer, resulting formulations | |
ATE374622T1 (de) | Genetische impstoffe mit adjuvans | |
ATE281843T1 (de) | Immunotherapie chronischer hepatitis b virusinfektion mittels dna-immunisierung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |